Skip to main content
NewslettersWatchlist

Aligos Therapeutics Inc(ALGS-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Aligos Therapeutics Inc

ONE CORPORATE DR. 2ND FLOOR
SOUTH SAN FRANCISCO CA 94080 USA
P: 800-466-6059
http://www.aligos.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is focused on the development of antiviral therapies for chronic hepatitis B and coronaviruses as well as liver diseases. Aligos Therapeutics, Inc. is based in SAN FRANCISCO, Calif.

    Key Executives

    NameTitle
    Lawrence M. BlattCEO/Chairman of the Board/Co-Founder/Director/President
    Lesley Ann CalhounCFO/Chief Accounting Officer/Executive VP
    Julian A. SymonsChief Scientific Officer/Executive VP
    Matthew W. McClureChief Medical Officer/Executive VP

    More from The Globe

    At midday: S&P, Nasdaq hit record highs as tepid inflation data fans rate cut bets
    Traders work on the floor of the New York Stock Exchange (NYSE) on May 3.
    Chevron tops Tesla as most-shorted stock in April, says Hazeltree
    The Chevron Pascagoula Refinery is pictured in Pascagoula, Mississippi on Sept. 4, 2018.
    The close: Nasdaq at record high after Fed chair’s comments but TSX dips for third day
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
    The close: S&P 500, TSX slip as investors await inflation data; meme rally reignites
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8.
    Shopify executive earned US$76-million in 2023, far outpacing CEO’s compensation
    Kaz Nejatian, COO of Shopify, speaks at the Collision conference in Toronto, Wednesday, June 28, 2023. THE CANADIAN PRESS/Chris Young
    Advantage Energy director buys as stock rallies
    Ted Dixon
    The close: S&P 500 higher but TSX slips as traders await key U.S. inflation data
    Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., May 8, 2024. REUTERS/Brendan McDermid/File Photo
    How pro money managers are balancing exposure to Canadian and U.S. stocks
    Rob Carrick

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.